A TrialAssure blog post starts with three words: planning, timing, and coordination to explain the formula that Sponsors should follow as the European Clinical Trials Regulation 536/2014 comes into full force in January 2022.
Author Karim Ibazatene, an Associate Director at MMS Holdings, writes that Pharma should focus on timelines to better capture the efficiencies that will come with the new regulations. To learn more, click here.
